The circular RNA MICRA for risk stratification after myocardial infarction☆

[1]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[2]  D. Barnett,et al.  Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction. , 2000, European heart journal.

[3]  A. Jaffe,et al.  Diseased skeletal muscle: a noncardiac source of increased circulating concentrations of cardiac troponin T. , 2011, Journal of the American College of Cardiology.

[4]  L. A. Bonet,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2012, Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir.

[5]  Y. Devaux,et al.  Association between circulating microRNAs, cardiovascular risk factors and outcome in patients with acute myocardial infarction. , 2013, International journal of cardiology.

[6]  Michael K. Slevin,et al.  Circular RNAs are abundant, conserved, and associated with ALU repeats. , 2013, RNA.

[7]  Y. Devaux,et al.  A Panel of 4 microRNAs Facilitates the Prediction of Left Ventricular Contractility after Acute Myocardial Infarction , 2013, PloS one.

[8]  Lu Zhang,et al.  MicroRNA-150: A Novel Marker of Left Ventricular Remodeling After Acute Myocardial Infarction , 2013, Circulation. Cardiovascular genetics.

[9]  N. Danchin,et al.  Door-to-balloon time and mortality. , 2014, The New England journal of medicine.

[10]  Y. Devaux,et al.  Long Noncoding RNAs in Patients With Acute Myocardial Infarction , 2014, Circulation research.

[11]  G. Lemesle,et al.  Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure , 2014, Circulation research.

[12]  J. Brophy,et al.  Door-to-balloon time and mortality. , 2014, The New England journal of medicine.

[13]  G. Lemesle,et al.  The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients , 2014 .

[14]  Petar Glažar,et al.  Circular RNAs in the Mammalian Brain Are Highly Abundant, Conserved, and Dynamically Expressed. , 2015, Molecular cell.

[15]  Lu Zhang,et al.  Myocardial Infarction-Associated Circular RNA Predicting Left Ventricular Dysfunction. , 2016, Journal of the American College of Cardiology.

[16]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[17]  M. Rayner,et al.  Cardiovascular disease in Europe: epidemiological update 2016. , 2016, European heart journal.

[18]  G. Condorelli,et al.  Circular RNAs and heart failure: new players for an old disease. , 2017, Cardiovascular research.

[19]  E. Creemers,et al.  Circular RNAs in heart failure , 2017, European journal of heart failure.

[20]  M. Wise,et al.  Incremental Value of Circulating MiR-122-5p to Predict Outcome after Out of Hospital Cardiac Arrest , 2017, Theranostics.

[21]  S. Solomon,et al.  Fussing Over the Middle Child: Heart Failure With Mid-Range Ejection Fraction. , 2017, Circulation.

[22]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[23]  Y. Devaux.  Transcriptome of blood cells as a reservoir of cardiovascular biomarkers. , 2017, Biochimica et biophysica acta. Molecular cell research.